Gastrointestinal Carcinoid Tumor
📧 Sign up to get email alerts when something new happens for Gastrointestinal Carcinoid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022
A completed SEER-based study analyzes two decades (2000–2022) of mortality risk in gastrointestinal carcinoid tumors. It updates prior estim…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Recent Trends in Stage Migration of Gastrointestnial Carcinoid Tumors Over Two Decades: a Retrospective SEER-based Analysis 2000-2022
A retrospective SEER-based analysis assessing how stage at diagnosis for gastrointestinal carcinoid tumors has changed over the period 2000–…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022
A SEER-based study (2000-2022) explores whether patients with a primary gastrointestinal carcinoid tumor have an increased risk of developin…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Cabozantinib and Nivolumab for Carcinoid Tumors [Phase 2]
A Phase 2 study evaluating the combination of cabozantinib and nivolumab for carcinoid tumors has completed with results posted in January 2…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers [Phase 1, Phase 2]
EMB-01 is being studied in a Phase 1/2 trial for advanced or metastatic gastrointestinal cancers and is currently recruiting. The sponsor is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of everolimus and vatalanib in patients with advanced solid tumors, including several neuroendocrin…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating regorafenib in advanced or metastatic neuroendocrine tumors has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors [Phase 2, Phase 3]
A phase 2/3 trial evaluating combination chemotherapy with bevacizumab in advanced neuroendocrine tumors has been terminated; results were p…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy plus interferon alfa followed by filgrastim in gastrointestinal tract cancers, completed.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors [NA]
Clinical trial update on doxorubicin-loaded beads for unresectable liver metastases from neuroendocrine tumors; the trial was terminated and…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating temsirolimus in patients with metastatic neuroendocrine tumors has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 trial update assesses the safety and feasibility of radiolabeled octreotide in pediatric patients with advanced or refractory s…
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating vatalanib in combination with octreotide for progressive neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating AMG 706 (motesanib) with octreotide in low-grade neuroendocrine tumors has completed enrollment and results were po…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with progressive metastatic neuroendocrine tumors has completed; results were posted…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [Phase 1]
Phase 1 trial evaluating Indium-111 pentetreotide in patients with refractory cancer across multiple tumor types. The study status is termin…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS research · 2013-10-29Clinical Trial Update: Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
A clinical trial update discusses a disease-specific questionnaire used to assess quality of life in patients with gastrointestinal-related …
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating capecitabine and streptozocin with or without cisplatin in unresectable or metastatic neuroendocrine tumors has com…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating thalidomide in metastatic neuroendocrine tumors has completed, including gastrointestinal carcinoid tumors and panc…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update evaluating gefitinib in patients with progressive/metastatic neuroendocrine tumors has completed. The study en…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of romidepsin for locally advanced or metastatic neuroendocrine tumors was terminated; the document lists the conditions studi…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors [Phase 2]
Phase 2 trial evaluating the combination of fluorouracil and interferon alfa in patients with advanced metastatic carcinoid tumors, includin…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of PS-341 (bortezomib) in metastatic neuroendocrine tumors has completed enrollment with status reported as completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors [Phase 2]
Phase 2 clinical trial evaluating the combination of bevacizumab and pegylated interferon alfa-2b in patients with metastatic or unresectabl…